SRx Global Inc

SRx Global Inc(SRXH)股票分析

$0.811

+0.011 (+1.39%)收盘时

Loading chart…
最高
0.838
开盘
0.808
成交量加权均价
0.81
成交量
280.74K
市值
—
最低
0.790
成交额
228.26K
企业价值/息税折旧摊销前利润(TTM)
0.00

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others.

AI 分析 of SRx Global Inc (SRXH)

卖出

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

估值指标

SRx Global Inc(SRXH)当前预期市盈率为 0.00,5 年平均预期市盈率为 0.00。

预期市盈率

严重低估
5 年均值 P/E
0.00
当前P/E
0.00
高估
0.00
低估
0.00

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 SRXH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%SRXH

$0.65

情景价格

基

基准

基准 · 50%SRXH

$0.61

情景价格

悲

悲观

悲观 · 25%SRXH

$0.58

情景价格

事件时间线

2026-08-04 (ET)

05:30:00

SRX Global Acquires Stake in Vistagen

2026-07-30 (ET)

14:30:00

SRX Global Acquires Shares in Jersey Mike's IPO

2026-07-09 (ET)

12:00:00

SRx Global Inc Trading Halted, News Pending

12:00:00

SRX Global Authorizes Repurchase of Up to 10M Shares

2026-07-08 (ET)

14:00:00

SRx Global Inc Trading Halted, News Pending

资讯

SRXH 常见问题 —— 由 Alphio AI 解答

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others. It operates in the Technology sector.

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易